Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients

Detalles Bibliográficos
Autores principales: Launois, R, Riou Franca, L, Guidet, B, Aegerter, P, Huet, X, Meshaka, P, Pinton, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333530/
http://dx.doi.org/10.1186/cc1570
_version_ 1782230463618744320
author Launois, R
Riou Franca, L
Guidet, B
Aegerter, P
Huet, X
Meshaka, P
Pinton, P
author_facet Launois, R
Riou Franca, L
Guidet, B
Aegerter, P
Huet, X
Meshaka, P
Pinton, P
author_sort Launois, R
collection PubMed
description
format Online
Article
Text
id pubmed-3333530
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33335302012-04-24 Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients Launois, R Riou Franca, L Guidet, B Aegerter, P Huet, X Meshaka, P Pinton, P Crit Care Meeting Abstract BioMed Central 2002 2002-03-01 /pmc/articles/PMC3333530/ http://dx.doi.org/10.1186/cc1570 Text en
spellingShingle Meeting Abstract
Launois, R
Riou Franca, L
Guidet, B
Aegerter, P
Huet, X
Meshaka, P
Pinton, P
Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title_full Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title_fullStr Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title_full_unstemmed Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title_short Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
title_sort cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3333530/
http://dx.doi.org/10.1186/cc1570
work_keys_str_mv AT launoisr costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT rioufrancal costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT guidetb costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT aegerterp costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT huetx costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT meshakap costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients
AT pintonp costeffectivenessanalysisofdrotrecoginalfaactivatedasatreatmentforseveresepsisinhospitalisedpatients

Ejemplares similares